Loading...

Investors

NEUTRISCI FORMS CANNABINOID JOINT VENTURE WITH LEXARIA BIOSCIENCE

VANCOUVER, BC – (Marketwired – April 10, 2017) – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) and Lexaria Bioscience Corp. (“Lexaria”) (CSE: LXX) (OTCQB: LXRP) are pleased to announce finalization of the joint venture between the companies to produce and commercialize a line of healthy, sugar-free, edible cannabinoid sublingual tablets combining NeutriSci’s proprietary pterostilbene tablet form factor and Lexaria’s patented technology.

The new company to be formed, Ambarii Trade Corporation (“Ambarii”), is initially being funded and owned equally by each of NeutriSci and Lexaria. NeutriSci and Lexaria are each contributing its respective technology to Ambarii by way of a license, and will split all profits derived from Ambarii operations on a 50/50 basis.

Ambarii will immediately work to secure licensees in California, Colorado and Canada, to manufacture and sell sublingual melt tablets containing THC and CBD. The products will also combine the benefits of both NeutriSci’s and Lexaria’s existing technologies and ingredient mixes. Initial manufacturing arrangements have been secured with a licensed entity in California which will begin large scale test runs in May, 2017 with plans to manufacture and test a fully functioning THC and CBD version of the product. In more developed legal markets such as California and Colorado, cannabis edibles often comprise 33% – 55% market share of all legal cannabis products, making high quality cannabis edibles vitally important to the marketplace.

Ambarii will also enter the hemp oil based market for sublingual melt products, which are not as highly regulated in some jurisdictions as THC-based products. Distribution for these products will be developed through NeutriSci’s existing network of retail distributors as well as other methods. Initial test production runs of the hemp oil variety of pterostilbene-containing products have already achieved very positive human focus group results, as previously announced.

Glen Rehman, President of NeutriSci stated, “We are thrilled to officially partner with Lexaria. As we continue our advanced discussions with some of Canada’s leading medical marijuana companies, this JV Agreement represents a giant leap forward for the development, sale and manufacturing of cannabis edibles. Ambarii will deliver an edible product that is not only highly effective, but also a healthy sugar free alternative powered by pterostilbene. The Ambarii product line will be world class, and will have high appeal to today’s health conscious medicinal and recreational users.”

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.getneuenergy.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

NEUTRISCI WELCOMES OLYMPIC GOLD MEDALISTS MICHELLE CAMERON COULTER AND AL COULTER AS NEUENERGY BRAND AMBASSADORS

VANCOUVER, BC – (Marketwired – March 30, 2017) – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce the addition of Olympic Gold medalists Michelle Cameron Coulter and Al Coulter to the Company’s neuenergy® Ambassador Marketing Program (“NAMP”).

MICHELLE CAMERON COULTER – Olympic Gold Medalist, entrepreneur, philanthropist, wife and mother of four.

At the 1988 Seoul Olympics Michelle won an Olympic Gold Medal in Synchronized Swimming. Michelle is a six-time World Champion and swam on the Canadian National team for over ten years. She became the first ever Albertan to win a Summer Olympic Gold Medal, and was inducted into Alberta and Canada’s Sports Halls of Fame, and the International Aquatic Sports Hall of Fame. Michelle was also awarded the Prestige’s Order of Canada as well as both the Queen Elizabeth II Golden and Diamond Jubilee Medals in recognition of her continued work and contribution to the community.

Al COULTER – 2-time Olympic athlete, world record holder and entrepreneur.

Al Coulter is known as the “Iron man of Volleyball” after playing on Team Canada for 13 years, participating in 2 Olympics and being Captain of Team Canada for 5 years. Al holds the world record in any sport for representing ones’ country for the most international matches; competing in over 735 international matches for Canada.

“I am honored to be part of the neuenergy brand,” says Michelle. “Aligning myself with a brand that is both healthy and works is vital to me. We all have busy days and to have found a product like neuenergy that gives me a clean boost of energy without all the caffeine and chemicals found in most energy drinks is super exciting.”

NeutriSci President Mr. Glen Rehman stated, “We are thrilled to have two Olympians in Michelle and Al as part of our neuenergy Ambassador Program. Al and Michelle are both very well respected in the community and within their respective sports. This opportunity to promote neuenergy is a win-win for everyone.”

NAMP allows the Company to build out a network of influencers, public figures, celebrities and entrepreneurs to help expand the neuenergy® brand. Commissions are earned from online sales that are generated from the direct referral of the Ambassador. This program is ideal for influencers, public figures, celebrities and entrepreneurs that the Company identifies as a good fit for the brand and product. It also gives Ambassadors the opportunity to monetize their social networks by generating sales of neuenergy® through their own referral network.

Neuenergy® is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products.

To find out more about the Michelle and Al’s Ambassador Program please visit:
https://neuenergy.me/allanandmichelle

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.getneuenergy.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

NEUTRISCI ANNOUNCES ADVANCED TALKS WITH SEVERAL OF CANADA’S LEADING MEDICAL MARIJUANA COMPANIES

VANCOUVER, BC – (Marketwired – March 29, 2017) – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, confirms it is in advanced discussions regarding product formulation with several of the top companies in Canada’s burgeoning cannabis sector.

NeutriSci has been working directly with several companies in Canada’s cannabis sector with a view to using NeutriSci’s proprietary formulation and form factor within the industry. This formulation utilizes NeutriSci’s melt technology and the pterostilbene molecule in combination with various cannabis and cannabidiol actives. Based on research to-date, the Company believes its formulation will enable manufacturers of edible cannabis products to use less active ingredients and better define dose control properties, while still achieving the same desired effects. These effects are like the mechanism that is achieved within neuenergy®, which increases the overall efficacy of standard caffeine by more than 5x.

NeutriSci President Mr. Glen Rehman stated, “We are excited about the potential synergies and partnerships these talks may produce. We have been working with these parties for several months now and are very encouraged with the progress to date.”

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.getneuenergy.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

NEUTRISCI ANNOUNCES LAUNCH OF NEW AMBASSADOR DIRECT SALES CHANNEL

VANCOUVER, BC – March 21, 2017 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce the launch of its ambassador marketing program for neuenergy®.

The Company has been beta testing the program for several months, and it is now being opened to ambassadors around the world, with an initial focus on North America, Europe and Southeast Asia.

The neuenergy® Ambassador Marketing Program (NAMP), allows the Company to build out a network of influencers, public figures, celebrities and entrepreneurs to help expand the neuenergy® brand. Commissions are earned from online sales that are generated from the direct referral of the Ambassador. This program is ideal for influencers, public figures, celebrities and entrepreneurs that the Company identifies as a good fit for the brand and product. It will give them the opportunity to monetize their social networks by generating sales of neuenergy® through their own referral network.

NeutriSci President Mr. Glen Rehman stated, “A solid brand ambassador program creates mutual benefits with cost-effective promotion for both parties. Ambassadors boost brand awareness in the target market and drive sales in a less expensive way than traditional channels. Our Ambassador program will promote trusted faces thus positively reinforcing neuenergy to their readers and followers. Ambassadors benefit because they receive commission on every sale they refer however these commissions only come from customers who convert, so both businesses and ambassadors benefit from a transparent and efficient working arrangement. We are very excited about the level of interest this program has already achieved, and look forward to announcing industry leading Ambassadors over the next few weeks.”

Neuenergy® is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products.

To find out more about neuenergy®, please visit www.getneuenergy.com.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.getneuenergy.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

NEUTRISCI ANNOUNCES DISTRIBUTION AGREEMENT & INITIAL ORDER OF NEUENERGY FROM GATEWAY NEWSTANDS

Vancouver, British Columbia – March 16, 2017 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce that neuenergy® is now available at Gateway Newstands across Canada and the United States.

Gateway Newstands is a chain of convenience stores and kiosks located in large office buildings, shopping centres, public places, and transit stations in the United States and Canada.

There are currently over 500 Gateway Newstand franchises in the network, of which 65 locations have been operated in the Toronto subway system since the mid-1990s. The stores sell a wide variety of convenience items from tobacco and lottery tickets; to candy, chewing gum, and non-alcoholic beverages; and newspapers and magazines.

NeutriSci President Mr. Glen Rehman stated, “We are very pleased to continue the expansion of our North American distribution network with such a strong company as Gateway Newstands. Gateway Newstands has a very captive audience as a result of the strategic placing of their stores in high traffic locations. In addition to Gateway Newstands, neuenergy is also available in a growing network of retailers that includes 7-Eleven, Save-on-Foods, Buy-Low, Sobey’s/Safeway, Mac’s, Overwaitea, Amazon and Meijer.”

Neuenergy® is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products.

To find out more about neuenergy®, please visit www.getneuenergy.com.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.getneuenergy.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

NEUTRISCI LAUNCHES NATIONAL TELEVISION AD CAMPAIGN

Vancouver, British Columbia – March 09, 2017 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce the launch of its national television campaign for neuenergy®.

The campaign consists of more than 1,400 thirty second spots over a 4-week period. The spots are airing now on major cable networks including, TSN, TSN2, Discovery, Discovery Velocity, National Geographic, Action, Game Show and BNN.

This is the first major ad campaign for neuenergy® in Canada, and coincides with the increasing demand for neuenergy® in the more “grown-up” segment of the Canadian energy drink and supplement market, which recorded sales in excess to $475 million in 2015.

To view commercial click on the link:

Neuenergy Commercial

NeutriSci President Mr. Glen Rehman stated, “This latest news helps solidify neuenergy as a competitive player in the Canadian market place. Neuenergy is now available across Canada with added distribution to be announced in the coming weeks. Our expanded national distribution provided us the ability to proceed with this major ad campaign as it allowed us to reach economies of scale. This television commercial represents the first of many national media campaigns planned for 2017.”

Neuenergy® is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products.

To find out more about neuenergy®, and to view this new television commercial, visit www.getneuenergy.com.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.getneuenergy.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

NEUTRISCI ANNOUNCES OTCQB LISTING

Vancouver, British Columbia – March 06, 2017 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) is pleased to announce that it has commenced trading on the OTCQB Marketplace under the symbol NRXCF.

NeutriSci President, Glen Rehman commented, “We are pleased to have been added to the OTCQB Marketplace. The Company’s common shares are now trading on three international platforms: TSX Venture (Canada), OTCQB (USA) and Frankfurt (Germany). Given the progress that the Company is making with the retail distribution of its energy supplement, neuenergy, and with its work on the neuenergy-CBD product that is being developed in partnership with Lexaria Bioscience, we believe that this most recent US listing will create greater visibility with US investors, allowing a much larger potential shareholder base and enhanced liquidity.”

The Company also announces that Arlene Dickinson has resigned as a director of the Company to focus on other endeavours. The Company thanks Arlene for her valuable marketing contributions to NeutriSci.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.getneuenergy.com.

 

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

NEUTRISCI ANNOUNCES SUCCESSFUL DEVELOPMENT AND POSITIVE RESULTS FROM INITIAL OBSERVATIONAL PRODUCT TRIALS WITH LEXARIA BIOSCIENCE

Vancouver, British Columbia – January 19, 2017 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, Frankfurt-1N9) and Lexaria Bioscience Corp. (“Lexaria”) (LXX.CN) are pleased to announce the successful development and initial trial of the industry’s first cannabinoid / pterostilbene edible tablet utilizing NeutriSci’s and Lexaria’s proprietary and patented technologies.

NeutriSci’s proprietary pterostilbene tablet formula and Lexaria’s technology were combined to produce the first market ready pterostilbene / cannabidiol (CBD) rapid melt edible product. The pre-trial hypothesis focused on whether the combination of NeutriSci’s patented pterostilbene formula and Lexaria’s patented CBD conjugation would prove effective in rapidity of onset, and strength of effect, while delivering improvements in taste.  These initial trial results have demonstrated that the consumer experiences positive effects that occur more immediately, and last longer, while utilizing dose-controlled amounts of CBD.

Based on these positive results, NeutriSci and Lexaria will formalize the JV agreement to market and commercialize a line of edible products using CBD derived from full spectrum hemp oil, which is legal throughout the United States, along with several tetrahydrocannabinol (THC) versions through distribution programs with both existing and new strategic partners.

“We are very pleased with the results of this observational trial, as the initial results have be invaluable in helping NeutriSci open dialogue with several of the world’s largest CBD manufacturers and distributors,” commented Glen Rehman, President of NeutriSci. “The idea of using our sublingual tablet and form factor to create a new line of zero-sugar and dose-controlled cannabinoid edible products will become a reality.  This new ground breaking proprietary tablet and form factor addresses what manufacturers, distributors and consumers have been asking, and positions us to be an industry leader in what will be a multi-billion-dollar industry.”

“This JV is a demonstration of the rapid innovation occurring in the cannabis industry,” commented Chris Bunka, CEO of Lexaria Bioscience. “We are excited to work with NeutriSci; using both company’s technologies, ingredients and form factor to develop healthy cannabinoid products.”

Following the recent approvals for recreational use in certain US states, Industry researchers have reported that the legal cannabis market could exceed $20 Billion by 2020.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.getneuenergy.com.

About Lexaria: Lexaria Bioscience Corp. is a food biosciences company with a proprietary technology for improved delivery of bioactive compounds. Lexaria’s lipophilic enhancement technology has been shown to enhance the bioavailability of orally ingested cannabinoids, while also masking taste. This technology promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery. Lexaria’s technology is patent-protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids, and patent-pending for Tetrahydrocannabinol (THC), other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.

www.lexariabioscience.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

NEUTRISCI ADDS SOBEYS & SAFEWAY TO ITS LIST OF CANADIAN RETAILERS

Vancouver, British Columbia – January 17, 2017 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, announces its latest distribution agreement with Sobeys and Safeway Canada.

Sobeys Inc. and Safeway Canada are wholly-owned subsidiaries of Empire Company Limited (“Empire”).  Empire is one of the largest food retailers in Canada, with over 260 Sobeys and 183 Safeway supermarkets operating in Canada, with an additional 1,200 stores operating under banners such as IGA and IGA Extra, Thrifty Foods, Foodland, FreshCo, Price Chopper, Lawtons Drugs, Rachelle-Béry, Needs, Marché Bonichoix and Les Marchés Tradition.

NeutriSci President Mr. Glen Rehman stated, “We are pleased to announce our most recent distribution agreement with one of Canada’s preeminent retail groups.  Sobeys and Safeway will offer Canadian consumers a trusted and well established brand in which to find neuenergy.  Continued growth and increased sales of neuenergy is directly proportional to the number of locations neuenergy can be purchased from; these new distribution partners help us achieve just that.  These increased distribution outlets are ultimately increasing revenue.”

Neuenergy® is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products.

To find out more about neuenergy®, please visit www.getneuenergy.com.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.neutrisci.com.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

NEUTRISCI ANNOUNCES MEMORANDUM OF UNDERSTANDING ESTABLISHING A 50/50 JOINT VENTURE WITH LEXARIA BIOSCIENCE

Vancouver, British Columbia – November 22, 2016 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, Frankfurt-1N9) and Lexaria Bioscience Corp. (“Lexaria”) (LXX.CN) are pleased to announce the signing of a Memorandum of Understanding forming a 50/50 Joint Venture (the “JV”) to develop and produce a line of healthy edible cannabinoid products using Lexaria’s patented technology and NeutriSci’s proprietary pterostilbene tablet formula and to distribute the products through NeutriSci’s international distribution network.

This JV will test and develop cannabinoid formulations based on NeutriSci’s proprietary sublingual pterostilbene zero-sugar tablet formula and form factor; combining Lexaria’s patented technology which improves the bioavailability and taste of orally ingested cannabinoids. Under the JV, the companies will first develop its edible product using cannabidiol (CBD) derived from full spectrum hemp oil, which is legal throughout the United States, followed by further development using other cannabinoid products such as tetrahydrocannabinol (THC). The JV will ultimately commercialize these potentially unique and proprietary edible products through distribution programs with existing strategic partners.

“We were immediately intrigued when we were approached with the idea of using our sublingual tablet and form factor to create a new line of zero-sugar and dose controlled cannabinoid edible products,” commented Glen Rehman, President of NeutriSci. “By combining Lexaria’s technology to mask taste and increase bioavailability, this JV has all the tools to create a whole new line of healthy cannabinoid edible products, which will have high appeal with today’s health conscious medicinal consumers and recreational users. Consumers and regulatory groups will seek a product that is convenient, safe, dose controlled, effective and ultimately great tasting. This new ground breaking proprietary tablet addresses all of those needs; becoming an industry leading solution in what will be a multi-billion-dollar industry. We expect to complete the JV agreement in the next 4 weeks.”

“This JV is a demonstration of the rapid innovation occurring in the cannabis industry,” commented Chris Bunka, CEO of Lexaria. “We are excited to work with NeutriSci; using both companies’ technologies, ingredients and form factor to develop healthy cannabinoid products sold within NeutriSci’s international distribution network.”

Following the recent approvals for recreational use in certain US states, industry researchers have reported that the legal cannabis market could exceed $20 Billion by 2020.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.getneuenergy.com.

About Lexaria: Lexaria Bioscience Corp. is a food biosciences company with a proprietary technology for improved delivery of bioactive compounds. Lexaria’s lipophilic enhancement technology has been shown to enhance the bioavailability of orally ingested cannabinoids, while also masking taste. This technology promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery. Lexaria’s technology is patent-protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids, and patent-pending for Tetrahydrocannabinol (THC), other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.

www.lexariabioscience.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

ABOUT US

NeutriSci International Inc. is an Alberta based marketing, development and distribution company targeting the multi-billion dollar Nutraceutical market. We develop effective marketing and branding strategies for nutraceutical partners around the world.

Privacy Policy

GET IN TOUCH

NeutriSci International Inc.
Toronto: (TSX-V: NU)
Frankfurt: (1N9)
OTCQB: (NRXCF)

Suite #1A, 4015 1st St SE

Calgary, AB, Canada
T2G 4X7

Office: 1.403.264.6320
Fax: 1.403.252.2106

Email: info@neutrisci.com

TRACK OUR STOCK
NU.V
+0.00%
NEUTRISCI INTERNATIONAL INC
  • Share price:
    0.12
  • Day high:
    0.13
  • Year high:
    0.25
@getneuenergy Updates